We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+29.7%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.09B
AUM Growth
+$568M
(+109%)
Cap. Flow
+$422M
Cap. Flow
% of AUM
38.69%
Top 10 Holdings %
Top 10 Hldgs %
23.6%
Holding
197
New
132
Increased
39
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$26.1M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$20M |
| 3 |
Arvinas
ARVN
|
+$19.8M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$19.7M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$18.2M |
| 2 |
KYNB
Kyntra Bio
KYNB
|
+$12M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.7M |
| 4 |
Teladoc Health
TDOC
|
+$10.1M |
| 5 |
Biogen
BIIB
|
+$8.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.26% |
| 2 | Industrials | 4.93% |
| 3 | Technology | 1.47% |
| 4 | Energy | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Integer Holdings
ITGR
$4.12B
| $365K | 0.03% |
+5,000
| New | +$364K |
|
152
LivaNova
LIVN
$4.4B
| $356K | 0.03% |
+7,400
| New | +$371K |
|
153
Axsome Therapeutics
AXSM
$11.2B
| $346K | 0.03% |
+4,200
| New | +$323K |
|
154
Pacira BioSciences
PCRX
$1.04B
| $331K | 0.03% |
+6,300
| New | +$263K |
|
155
The Ensign Group
ENSG
$10.4B
| $326K | 0.03% |
+7,800
| New | +$309K |
|
|
SAGE
156
DELISTED
Sage Therapeutics
SAGE
| $324K | 0.03% |
+7,800
| New | +$283K |
|
157
Allogene Therapeutics
ALLO
$649M
| $317K | 0.03% |
+7,400
| New | +$268K |
|
158
CONMED
CNMD
$1.39B
| $295K | 0.03% |
+4,100
| New | +$285K |
|
159
Vir Biotechnology
VIR
$1.46B
| $291K | 0.03% |
+7,100
| New | +$238K |
|
160
Tenet Healthcare
THC
$20.5B
| $290K | 0.03% |
+16,000
| New | +$315K |
|
161
Prestige Consumer Healthcare
PBH
$2.38B
| $289K | 0.03% |
+7,700
| New | +$308K |
|
|
PDCO
162
DELISTED
Patterson Companies, Inc.
PDCO
| $286K | 0.03% |
+13,000
| New | +$228K |
|
163
Healthcare Services Group
HCSG
$1.6B
| $279K | 0.03% |
+11,400
| New | +$270K |
|
164
Xencor
XNCR
$1.5B
| $275K | 0.03% |
+8,500
| New | +$261K |
|
|
ALLK
165
DELISTED
Allakos
ALLK
| $266K | 0.02% |
+3,700
| New | +$248K |
|
|
CMD
166
DELISTED
Cantel Medical Corporation
CMD
| $257K | 0.02% |
+5,800
| New | +$216K |
|
|
MGLN
167
DELISTED
Magellan Health Services, Inc.
MGLN
| $255K | 0.02% |
+3,500
| New | +$224K |
|
168
Ironwood Pharmaceuticals
IRWD
$696M
| $252K | 0.02% |
+24,400
| New | +$250K |
|
169
Editas Medicine
EDIT
$396M
| $251K | 0.02% |
+8,500
| New | +$222K |
|
170
Corcept Therapeutics
CORT
$12.4B
| $247K | 0.02% |
+14,700
| New | +$207K |
|
171
Glaukos
GKOS
$9.83B
| $246K | 0.02% |
+6,400
| New | +$238K |
|
172
Ligand Pharmaceuticals
LGND
$5.76B
| $246K | 0.02% |
+3,527
| New | +$224K |
|
|
SEM
173
DELISTED
Select Medical
SEM
| $245K | 0.02% |
+30,810
| New | +$255K |
|
174
Kodiak Sciences
KOD
$2.6B
| $238K | 0.02% |
+4,400
| New | +$248K |
|
175
Denali Therapeutics
DNLI
$3.65B
| $232K | 0.02% |
+9,600
| New | +$226K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Sectoral Asset Management held 197 positions worth $1.09B, up 109% from $521M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $422M of net new capital in Q2 2020, opening 132 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 401,158 shares worth $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Aprea Therapeutics, an estimated $18.2M trimmed.
- Sectoral Asset Management's largest Q2 2020 buy was Centene: 401,158 shares worth $25.5M.
- Sectoral Asset Management added most to Cardiovascular Systems, Inc. in Q2 2020, an estimated $18.2M increase.
- Sectoral Asset Management's biggest Q2 2020 reduction was Aprea Therapeutics, cutting an estimated $18.2M.
- Sectoral Asset Management fully exited Inspire Medical Systems in Q2 2020, selling an estimated $6.81M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $1.09B portfolio in Q2 2020.
- Sectoral Asset Management opened 132 new positions and closed 6 in Q2 2020.
- Sectoral Asset Management's portfolio value rose 109% quarter-over-quarter to $1.09B.
Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.